300453 三鑫医疗
已收盘 07-19 15:00:00
资讯
新帖
简况
三鑫医疗最新公告:控股子公司一次性使用球囊扩充压力泵获得医疗器械注册证
证券之星 · 07-19 20:10
三鑫医疗最新公告:控股子公司一次性使用球囊扩充压力泵获得医疗器械注册证
三鑫医疗(300453.SZ)控股子公司钶维肽取得一项医疗器械注册证
智通财经 · 07-19 19:37
三鑫医疗(300453.SZ)控股子公司钶维肽取得一项医疗器械注册证
三鑫医疗(300453.SZ)子公司黑龙江鑫品晰完成整改验收并恢复生产
智通财经 · 06-28
三鑫医疗(300453.SZ)子公司黑龙江鑫品晰完成整改验收并恢复生产
三鑫医疗最新公告:控股子公司完成整改验收并恢复生产
证券之星 · 06-28
三鑫医疗最新公告:控股子公司完成整改验收并恢复生产
三鑫医疗:公司将在《2024年半年度报告》中披露定期报告时点2024年6月30日的股东总数
证券之星 · 06-27
三鑫医疗:公司将在《2024年半年度报告》中披露定期报告时点2024年6月30日的股东总数
三鑫医疗(300453.SZ)拟授出829.57万股限制性股票 授予价为3.5元/股
智通财经 · 06-06
三鑫医疗(300453.SZ)拟授出829.57万股限制性股票 授予价为3.5元/股
三鑫医疗(300453.SZ):财务总监邹蓓廷辞职
智通财经 · 05-31
三鑫医疗(300453.SZ):财务总监邹蓓廷辞职
三鑫医疗(300453.SZ)子公司黑龙江鑫品晰被药监局责令停产整改
智通财经网 · 05-27
三鑫医疗(300453.SZ)子公司黑龙江鑫品晰被药监局责令停产整改
【机构调研记录】博时基金调研三鑫医疗、中控技术等9只个股(附名单)
证券之星 · 05-24
【机构调研记录】博时基金调研三鑫医疗、中控技术等9只个股(附名单)
【机构调研记录】华宝基金调研伊戈尔、三鑫医疗等7只个股(附名单)
证券之星 · 05-24
【机构调研记录】华宝基金调研伊戈尔、三鑫医疗等7只个股(附名单)
【机构调研记录】东财基金调研三鑫医疗、润都股份
证券之星 · 05-24
【机构调研记录】东财基金调研三鑫医疗、润都股份
三鑫医疗最新公告:获血液透析浓缩物医疗器械注册证
证券之星 · 04-29
三鑫医疗最新公告:获血液透析浓缩物医疗器械注册证
三鑫医疗(300453.SZ)获得血液透析浓缩物医疗器械注册证
智通财经 · 04-29
三鑫医疗(300453.SZ)获得血液透析浓缩物医疗器械注册证
三鑫医疗(300453.SZ)全资子公司江西圣丹康收到医疗器械生产许可证
智通财经网 · 04-09
三鑫医疗(300453.SZ)全资子公司江西圣丹康收到医疗器械生产许可证
加载更多
公司概况
公司名称:
江西三鑫医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2015-05-15
主营业务:
江西三鑫医疗科技股份有限公司(原江西三鑫医疗器械集团有限公司)是专业从事医疗器械研发、制造和销售的国家高新技术企业,主要产品为血液净化类产品、注射类产品、留置导管类产品、输液输血类产品、心胸外科类、防护类等。公司深入开展行业关键技术研发攻关,强化自主创新能力,以科技创新驱动公司高质量发展,被国家知识产权局认定为“国家知识产权优势企业”;“血液透析器的医用聚醚砜(PES)材料国产化制备技术及产业化研究”入选为国家工信部生物医用材料创新任务揭榜挂帅揭榜单位,公司“新型血液透析器及膜纺丝关键技术开发”被江西省科学技术厅认定为江西省科学技术成果,经专家评定为国际先进水平;公司“复合抗凝血涂层在介入医疗器械的应用研究项目”被列入2023年江西省重点研发计划;公司透析液过滤器完成重点新产品验收,评价为国际先进水平。
发行价格:
12.87
{"stockData":{"symbol":"300453","market":"SZ","secType":"STK","nameCN":"三鑫医疗","latestPrice":6.34,"timestamp":1721372610000,"preClose":6.34,"halted":0,"volume":3347583,"delay":0,"floatShares":363000000,"shares":520000000,"eps":0.4147,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"07-19 15:00:00","open":6.31,"high":6.42,"low":6.21,"amount":21140200,"amplitude":0.0331,"askPrice":6.35,"askSize":313,"bidPrice":6.34,"bidSize":27,"shortable":0,"etf":0,"ttmEps":0.4147,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":6.34,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":6.97,"lowLimit":5.71,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":519596545,"pbRate":2.62,"roa":"--","roe":"4.26%","epsLYR":0.3987,"committee":-0.764874,"marketValue":3294000000,"floatMarketCap":2302000000,"peRate":15.28816,"changeRate":0,"turnoverRate":0.0092,"status":2},"requestUrl":"/m/hq/s/300453","defaultTab":"news","newsList":[{"id":"2452345475","title":"三鑫医疗最新公告:控股子公司一次性使用球囊扩充压力泵获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2452345475","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452345475?lang=zh_cn&edition=full","pubTime":"2024-07-19 20:10","pubTimestamp":1721391046,"startTime":"0","endTime":"0","summary":"三鑫医疗公告,控股子公司一次性使用球囊扩充压力泵获得医疗器械注册证,用于血管介入手术中,与球囊扩张导管连接使用,通过压力表显示的压力值,对球囊作精确充盈及收缩,从而达到扩张或收缩球囊的目的。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900047875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","159883","BK1100","BK1583","BK0251","300453","BK1574","BK1222","09997"],"gpt_icon":0},{"id":"2452422823","title":"三鑫医疗(300453.SZ)控股子公司钶维肽取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2452422823","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452422823?lang=zh_cn&edition=full","pubTime":"2024-07-19 19:37","pubTimestamp":1721389062,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)公告,公司控股子公司江西钶维肽生物科技有限公司(简称“钶维肽”)于近日取得了江西省药品监督管理局颁发的《医疗器械注册证》,产品名称为:一次性使用球囊扩充压力泵。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","300453","09996","BK1574","BK1222","09997","BK0251","BK1583"],"gpt_icon":0},{"id":"2446688808","title":"三鑫医疗(300453.SZ)子公司黑龙江鑫品晰完成整改验收并恢复生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2446688808","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446688808?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581467,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)发布公告,2024年6月28日,公司控股子公司黑龙江鑫品晰医疗科技有限公司(简称“黑龙江鑫品晰”)收到黑龙江省药品监督管理局下发的《解除暂停生产决定书》,经黑龙江省药品监督管理局检查组确认,黑龙江鑫品晰已完成全部缺陷问题的整改,现依据相关法律法规解除黑龙江鑫品晰暂停生产的决定。黑龙江鑫品晰即日起将按照有关法律法规要求平稳有序恢复生产。公司将进一步加强对子公司的监督与管理,要求各子公司严格按照法律法规进行生产经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2446500382","title":"三鑫医疗最新公告:控股子公司完成整改验收并恢复生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2446500382","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446500382?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:10","pubTimestamp":1719580207,"startTime":"0","endTime":"0","summary":"三鑫医疗公告,6月28日,公司控股子公司黑龙江鑫品晰医疗科技有限公司收到黑龙江省药监局下发的《解除暂停生产决定书》,经黑龙江省药监局检查组确认,黑龙江鑫品晰已完成全部缺陷问题的整改,现依据相关法律法规解除黑龙江鑫品晰暂停生产的决定。黑龙江鑫品晰即日起将按照有关法律法规要求平稳有序恢复生产。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800050878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2446386055","title":"三鑫医疗:公司将在《2024年半年度报告》中披露定期报告时点2024年6月30日的股东总数","url":"https://stock-news.laohu8.com/highlight/detail?id=2446386055","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446386055?lang=zh_cn&edition=full","pubTime":"2024-06-27 19:00","pubTimestamp":1719486054,"startTime":"0","endTime":"0","summary":"证券之星消息,三鑫医疗(300453)06月27日在投资者关系平台上答复投资者关心的问题。投资者:请问截止到2024年6月20日股东户数是多少?三鑫医疗董秘:尊敬的投资者,您好!公司将在《2024年半年度报告》中披露定期报告时点2024年6月30日的股东总数。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062700034930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2441711627","title":"三鑫医疗(300453.SZ)拟授出829.57万股限制性股票 授予价为3.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441711627","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441711627?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:50","pubTimestamp":1717678217,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)披露2024年限制性股票激励计划(草案),公司拟向激励对象(共计69人)授予829.565万股,限制性股票的授予价格为3.50元/股。本激励计划的有效期为自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销之日止,最长不超过48个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2439935219","title":"三鑫医疗(300453.SZ):财务总监邹蓓廷辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2439935219","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439935219?lang=zh_cn&edition=full","pubTime":"2024-05-31 20:03","pubTimestamp":1717157005,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)发布公告,公司董事会于近日收到财务总监邹蓓廷提交的书面辞职报告,邹蓓廷因个人原因申请辞去公司财务总监职务,其原定任期为2023年4月13日至2026年4月12日,辞职后邹蓓廷将不再担任公司及子公司的任何职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1129333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2438381966","title":"三鑫医疗(300453.SZ)子公司黑龙江鑫品晰被药监局责令停产整改","url":"https://stock-news.laohu8.com/highlight/detail?id=2438381966","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438381966?lang=zh_cn&edition=full","pubTime":"2024-05-27 20:42","pubTimestamp":1716813722,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)发布公告,公司收到控股子公司黑龙江鑫品晰医疗科技有限...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astock/6.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/6.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1126731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2437749102","title":"【机构调研记录】博时基金调研三鑫医疗、中控技术等9只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2437749102","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437749102?lang=zh_cn&edition=full","pubTime":"2024-05-24 08:01","pubTimestamp":1716508890,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及5月23日披露的机构调研信息,博时基金近期对9家上市公司进行了调研,相关名单如下:1)三鑫医疗 个股亮点:获得一次性使用医用口罩、医用外科口罩临时备案凭证;公司“5G+智慧工厂”项目入选江西省工业和信息化厅 2023 年“5G+工业互联网”应用示范项目名单2)中控技术 个股亮点:公司GDR已经于2023-04-17成功上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400011709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","688777","BK0231","BK0251"],"gpt_icon":0},{"id":"2437749437","title":"【机构调研记录】华宝基金调研伊戈尔、三鑫医疗等7只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2437749437","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437749437?lang=zh_cn&edition=full","pubTime":"2024-05-24 08:01","pubTimestamp":1716508888,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及5月23日披露的机构调研信息,华宝基金近期对7家上市公司进行了调研,相关名单如下:1)伊戈尔 个股亮点:公司产品主要集中应用于节能、高效、前景广的照明、工业自动化及清洁能源行业;公司生产的高频电感可应用在800V的充电桩的电源模块上。6)泰和新材 个股亮点:公司氨纶产品属于聚氨酯;公司拥有第三代制氢隔膜技术;公司产品制成的芳纶蜂窝芯材在国产高速列车上已有应用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400011707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0224","300453","BK0251","002922"],"gpt_icon":0},{"id":"2437774913","title":"【机构调研记录】东财基金调研三鑫医疗、润都股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2437774913","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437774913?lang=zh_cn&edition=full","pubTime":"2024-05-24 08:01","pubTimestamp":1716508870,"startTime":"0","endTime":"0","summary":";公司雷贝拉唑钠肠溶胶囊产品辅助用于胃溃疡或十二指肠溃疡患者根除幽门螺旋杆菌。东财基金成立于2018年,截至目前,资产管理规模56.58亿元,排名149/203;资产管理规模56.58亿元,排名129/203;管理公募基金数89只,排名69/203;旗下公募基金经理12人,排名98/203。旗下最近一年表现最佳的公募基金产品为东财家电A,最新单位净值为0.99,近一年增长17.51%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400011684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300453","BK0251","002923"],"gpt_icon":0},{"id":"2431283536","title":"三鑫医疗最新公告:获血液透析浓缩物医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2431283536","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431283536?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:20","pubTimestamp":1714386047,"startTime":"0","endTime":"0","summary":"三鑫医疗公告,公司于近日取得了国家药品监督管理局颁发的医疗器械注册证,获证产品为血液透析浓缩物。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900024291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159883","BK1574","300453","09997","BK1222","BK1583","BK1100","09996"],"gpt_icon":0},{"id":"2431439833","title":"三鑫医疗(300453.SZ)获得血液透析浓缩物医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2431439833","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431439833?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:15","pubTimestamp":1714385731,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)公告,公司于近日取得了国家药品监督管理局颁发的《医疗器械注册证》,产品名称为血液透析浓缩物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","BK0251","BK1100","09996","09997","159883","BK1222","BK1583","BK1574"],"gpt_icon":0},{"id":"2426161326","title":"三鑫医疗(300453.SZ)全资子公司江西圣丹康收到医疗器械生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2426161326","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426161326?lang=zh_cn&edition=full","pubTime":"2024-04-09 18:45","pubTimestamp":1712659500,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)公告,公司全资子公司江西圣丹康医学科技有限公司(简称“江西圣丹康”)取得江西省药品监督管理局颁发的《医疗器械生产许可证》。公告显示,江西圣丹康专业从事慢性肾病医疗装备、中药结肠透析、中药与器械结合等相关产品的研发及医疗器械产品的销售和服务。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inarfrzs3034325.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inarfrzs3034325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1222","300453","BK1100","BK1574","159883","09997","09996","BK1583","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-05-15","address":"江西省南昌市南昌县小蓝经济开发区富山大道999号","stockEarnings":[{"period":"1week","weight":-0.0394},{"period":"1month","weight":-0.0579},{"period":"3month","weight":-0.1074},{"period":"6month","weight":-0.0936},{"period":"1year","weight":-0.0498},{"period":"ytd","weight":-0.1518}],"companyName":"江西三鑫医疗科技股份有限公司","boardCode":"AI0035","perCapita":"19868股","boardName":"专用设备制造业","registeredCapital":"51959万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 江西三鑫医疗科技股份有限公司(原江西三鑫医疗器械集团有限公司)是专业从事医疗器械研发、制造和销售的国家高新技术企业,主要产品为血液净化类产品、注射类产品、留置导管类产品、输液输血类产品、心胸外科类、防护类等。公司深入开展行业关键技术研发攻关,强化自主创新能力,以科技创新驱动公司高质量发展,被国家知识产权局认定为“国家知识产权优势企业”;“血液透析器的医用聚醚砜(PES)材料国产化制备技术及产业化研究”入选为国家工信部生物医用材料创新任务揭榜挂帅揭榜单位,公司“新型血液透析器及膜纺丝关键技术开发”被江西省科学技术厅认定为江西省科学技术成果,经专家评定为国际先进水平;公司“复合抗凝血涂层在介入医疗器械的应用研究项目”被列入2023年江西省重点研发计划;公司透析液过滤器完成重点新产品验收,评价为国际先进水平。","serverTime":1721470992975,"listedPrice":12.87,"stockholders":"18277人(较上一季度增加2.28%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三鑫医疗,300453,三鑫医疗股票,三鑫医疗股票老虎,三鑫医疗股票老虎国际,三鑫医疗行情,三鑫医疗股票行情,三鑫医疗股价,三鑫医疗股市,三鑫医疗股票价格,三鑫医疗股票交易,三鑫医疗股票购买,三鑫医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}